Fig. 1From: CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumorsExamples of absent (a), weak (b) moderate (c) and strong (d) CXCL12 in seminoma (a), embryonal carcinoma (b & d) and yolk sac (c) tumor componentsBack to article page